The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Chickenpox rash in an adult male
Chickenpox rash in an adult male

Chickenpox is caused by initial infection with varicella zoster virus, a DNA virus of the Alphaherpesvirinae subfamily. The virus naturally infects only humans, but some other primates have been infected artificially. Symptoms appear 10–21 days after exposure: an itchy vesicular skin rash, and small ulcers in the oral cavity and tonsil areas. The rash usually resolves by 7 days, but the virus remains latent in nerve cell bodies, and can emerge years or decades later to cause shingles. Chickenpox is transmitted by the respiratory route, as well as direct contact with lesions.

A classic disease of childhood, the highest prevalence occurs at 4–10 years. Chickenpox is rarely fatal in people with a normal immune system, with around 6,400 deaths worldwide in 2015, about 1 in 60,000 infections. Adults often have more severe symptoms than children, and are at higher risk of complications such as pneumonia, bronchitis, hepatitis and encephalitis. Pregnant women and people with a suppressed immune system have the highest complication risk. Chickenpox during the first 28 weeks of gestation can lead to foetal malformations. Infection in adults is usually treated with antiviral drugs, such as aciclovir or valaciclovir, which reduces symptom severity and the risk of complications. A vaccine is available.

Selected image

Chikungunya virus structure, based on cryoelectron microscopy

Chikungunya virus is an alphavirus transmitted by Aedes mosquitoes. The disease can cause severe joint pain, sometimes lasting for several months. Outbreaks have occurred across Africa, Asia and India, and in 2013–14, in South America and the Caribbean.

Credit: A2-33 (8 December 2013)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Child receiving oral polio vaccine in India
Child receiving oral polio vaccine in India

Vaccination or immunisation is the administration of immunogenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a virus or other pathogen, and so develop protection against an infectious disease. The active agent of a vaccine may be intact but inactivated or weakened forms of the pathogen, or purified highly immunogenic components, such as viral envelope proteins. Smallpox was the first disease for which a vaccine was produced, by Edward Jenner in 1796.

Vaccination is the most effective method of preventing infectious diseases and can also ameliorate the symptoms of infection. When a sufficiently high proportion of a population has been vaccinated, herd immunity results. Widespread immunity due to mass vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio from much of the world. Since their inception, vaccination efforts have met with objections on scientific, ethical, political, medical safety and religious grounds, and the World Health Organization considers vaccine hesitancy an important threat to global health.

Selected outbreak

Villagers in Yambuku, Zaire, being examined by staff from the US CDC

The 1976 Zaire Ebola virus outbreak was one of the first two recorded outbreaks of the disease. The causative agent was identified as a novel virus, named for the region's Ebola River. The first identified case, in August, worked in the school in Yambuku, a small rural village in Mongala District, north Zaire. He had been treated for suspected malaria at the Yambuku Mission Hospital, which is now thought to have spread the virus by giving vitamin injections with inadequately sterilised needles, particularly to women attending prenatal clinics. Unsafe burial practices also spread the virus.

The outbreak was contained by quarantining local villages, sterilising medical equipment and providing protective clothing to medical personnel, and was over by early November. A total of 318 cases was recorded, of whom 280 died, an 88% case fatality rate. An earlier outbreak in June–November in Nzara, Sudan, was initially thought to be linked, but was shown to have been caused by a different species of Ebola virus.

Selected quotation

Hiroyuki Ogata & Jean-Michel Claverie on the relationship between Sputnik virophage and mimivirus

Recommended articles

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses • Playa de Oro virus • poliovirus • prion • rotavirus • virus

Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White

Selected virus

Diagram of HIV structure

Human immunodeficiency virus (HIV) is a lentivirus, an RNA virus in the retrovirus family. Two types of HIV have been characterised: HIV-1 is the more virulent and is responsible for most infections worldwide; HIV-2 is mainly confined to West Africa. The genome consists of two copies of a single-stranded +RNA, which contains nine genes. The roughly spherical virus particle has a diameter of about 120 nm; it is enveloped and contains a conical capsid made of around 2,000 copies of the p24 protein. The envelope glycoprotein, a trimeric complex of gp120 and gp41, binds to CD4, the primary receptor on the host cell.

Transmission occurs by the transfer of bodily fluids including blood, semen, vaginal fluids and breast milk, in which the virus is present both as free virus particles and within infected immune cells. HIV infects key cells in the human immune system including CD4+ T helper cells, macrophages and dendritic cells. Infection leads to low levels of CD4+ T cells via several mechanisms, resulting in a progressive immunodeficiency disease known as AIDS.

Did you know?

Pringamoza
Pringamoza

Selected biography

Ali Maow Maalin (1954 – 22 July 2013) was a hospital cook and health worker from Merca, Somalia, who is the last person in the world known to be infected with naturally occurring smallpox. Although he worked in the local smallpox eradication programme, he had not been successfully vaccinated. In October 1977, he was infected with the Variola minor strain of the virus while driving two children with smallpox symptoms to quarantine. He did not experience complications and made a full recovery. An aggressive containment campaign was successful in preventing an outbreak, and smallpox was declared to have been eradicated globally by the World Health Organization (WHO) two years later.

In later life, Maalin volunteered for the successful poliomyelitis eradication campaign in Somalia. He worked for WHO as a local coordinator with responsibility for social mobilisation, and spent several years travelling across Somalia, vaccinating children and educating communities. He encouraged people to be vaccinated by sharing his experiences with smallpox. He died of malaria while carrying out polio vaccinations after the reintroduction of poliovirus to the country in 2013.

In this month

Red ribbon signifying solidarity with people living with HIV/AIDS

5 June 1981: First report of HIV/AIDS (symbol pictured) appeared in medical literature

6 June 1997: Gene silencing in plants shown to be a viral defence mechanism

7–13 June 1962: Donald Caspar and Aaron Klug proposed the quasi-equivalence principle of virus structure

7–13 June 1962: André Lwoff proposed a viral classification scheme based on nature of genome, type of symmetry and presence of envelope

7–13 June 1962: George Hirst proposed that the influenza virus genome is segmented

9 June 1981: The American Society for Virology was founded

13 June 2012: First case of Middle East respiratory syndrome coronavirus (MERS-CoV) occurred in Saudi Arabia

18 June 1981: A vaccine against foot-and-mouth disease was the first genetically engineered vaccine

21 June 1996: Nevirapine approved, first NNRTI for HIV/AIDS

26 June 1993: Clinical trial of hepatitis B virus drug fialuridine terminated; the drug caused several fatalities due to lactic acidosis

28 June 2011: FAO declared rinderpest eradicated

30 June 1985: Ryan White was denied re-admittance to his school after an AIDS diagnosis, in a case that changed public perceptions of the disease

Selected intervention

Ball-and-stick model of ribavirin
Ball-and-stick model of ribavirin

Ribavirin is a nucleoside analogue that mimics the nucleoside guanosine. It shows some activity against a broad range of DNA and RNA viruses, but is less effective against dengue fever, yellow fever and other flaviviruses. The drug was first synthesised in the early 1970s by Joseph T. Witkowski and Roland K. Robins. Ribavirin's main current use is against hepatitis C, in combination with pegylated interferon, nucleotide analogues and protease inhibitors. It has been used in the past in an aerosol formulation against respiratory syncytial virus-related diseases in children. Ribavirin has been used in combination as part of an experimental treatment for rabies. It is also the only available treatment for the viruses causing some viral haemorrhagic fevers, including Lassa fever, Crimean–Congo haemorrhagic fever and hantavirus disease, but is ineffective against the filovirus diseases, Ebola and Marburg. Clinical use is limited by the drug building up in red blood cells to cause haemolytic anaemia.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: